Monic Stuart
Chief Tech/Sci/R&D Officer bei MARKER THERAPEUTICS, INC.
Profil
Dr. Monic Stuart, MD, is a Chief Medical Officer at Marker Therapeutics, Inc. Dr. Stuart was previously employed as a Vice President-Clinical Development by Geron Corp.
and a Senior Medical Director by Genentech, Inc. He received his undergraduate degree from the University of North Carolina at Chapel Hill, a graduate degree from The Johns Hopkins University and a doctorate degree from the University of North Carolina at Chapel Hill.
Aktive Positionen von Monic Stuart
| Unternehmen | Position | Beginn |
|---|---|---|
| MARKER THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 08.05.2023 |
Ehemalige bekannte Positionen von Monic Stuart
| Unternehmen | Position | Ende |
|---|---|---|
| GERON CORPORATION | Chief Tech/Sci/R&D Officer | 01.02.2012 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | 01.01.2009 |
Ausbildung von Monic Stuart
| The Johns Hopkins University | Graduate Degree |
| University of North Carolina at Chapel Hill | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| GERON CORPORATION | Health Technology |
| MARKER THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
